Request a copy

Full Text

• Eastell, R., Management of corticosteroid-induced osteoporosis (1995) J Intern Med, 237, pp. 439-447
• Reid, I.R., Glucocorticoid-induced osteoporosis (1998) J Clin Densitom, 1, pp. 65-73
• Cushing, H., The basophil adenomas of the pituitary body and their clinical manifestations (1932) Bull Johns Hopkins Hosp, 50, pp. 137-195
• Lukert, B.P., Raisz, L.G., Glucocorticoid-induced osteoporosis: Pathogenesis and management (1990) Ann Intern Med, 112, pp. 352-364
• Ishida, Y., Heersche, J., Glucocorticoid-induced osteoporosis: Both in vivo and in vitro concentrations of glucocorticoids higher than physiological level attenuate osteoblast differentiation (1998) J Bone Miner Res, 13, pp. 1822-1826
• Dempster, D.W., Bone histomorphometry in glucocorticoid-induced osteoporosis (1989) J Bone Miner Res, 4, pp. 137-141
• Bressot, C., Meunier, P.J., Chapuy, M.C., Lejeune, E., Edouard, C., Darby, A.J., Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis (1979) Metab Bone Dis Rel Res, 1, pp. 303-311
• Dempster, D.W., Arlot, M.A., Meunier, P.J., Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis (1983) Calcif Tiss Int, 35, pp. 410-417
• Adachi, J.D., Corticosteroid-induced osteoporosis (1997) Am J Med Sci, 313, pp. 41-49
• Reid, I.R., Pathogenesis and treatment of steroid osteoporosis (1989) Clin Endocrinol (Oxf), 30, pp. 83-103
• Hahn, T.J., Halstead, L.R., Baran, D.T., Effects of short-term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentration in man (1981) J Clin Endocrinol Metab, 52, pp. 111-115
• Klein, R.G., Arnaud, S.B., Galagher, J.C., Deluca, H.F., Riggs, B.L., Intestinal calcium absorption in exogenous hypercortisolism (1977) J Clin Invest, 60, pp. 253-259
• Suzuki, Y., Ichikawa, Y., Saito, E., Homma, M., Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy (1983) Metabolism, 32, pp. 151-156
• Nielsen, H.K., Thomsen, K., Eriksen, E.F., Charles, P., Storm, T., Mosekilde, L., The effect of high-dose glucocorticoid administration on serum bone gamma-carboxyglutamatic acid containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects (1987) Bone Miner, 4, p. 105
• Garnero, P., Sornay-Rendu, E., Chapuy, M.C., Delmas, P.D., Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis (1996) J Bone Miner Res, 11, pp. 337-349
• Delmas, P.D., Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease (1990) Endocrinol Metab Clin North Am, 19, pp. 1-18
• Delmas, P.D., Biochemical markers of bone turnover. I. Theoretical considerations and clinical use in osteoporosis (1993) Am J Med, 95, pp. 11S-16S
• De Vernejoul, M.C., Markers of bone remodelling in metabolic bone disease (1998) Drugs Aging, 12 (1 SUPPL.), pp. 9-14
• Bikle, D.D., Biochemical markers in the assessment of bone disease (1997) Am J Med, 103, pp. 427-436
• Christenson, R.H., Biochemical markers of bone metabolism: An overview (1997) Clin Biochem, 30, pp. 573-593
• Nielsen, H.K., Thomsen, K., Eriksen, E.F., Charles, P., Storm, T., Mosekilde, L., The effect of high-dose glucocorticoid administration on serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects (1988) Bone Miner, 4, pp. 105-113
• Godschalk, M.F., Downs, R., Effect of short-term glucocorticoids on serum osteocalcin in healthy young men (1988) J Bone Miner Res, 3, pp. 113-115
• Gram, J., Junker, P., Nielsen, H.K., Bollerslev, J., Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men (1998) Bone, 23, pp. 297-302
• Piovesan, A., Terzolo, M., Reimondo, G., Pia, A., Codegone, A., Oselle, G., Boccuzzi, A., Angeli, A., Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome (1994) Horm Metab Res, 26, pp. 234-237
• Hermus, A.R., Smals, A.G., Swinkels, L.M., Huysmans, D.A., Pieters, G.F., Sweep, C.F., Corstens, F.H., Kloppenborg, P.W., Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome (1995) J Clin Endocrinol Metab, 80, pp. 2859-2865
• Sartorio, A., Ambrosi, B., Colombo, P., Morabito, F., Faglia, G., Osteocalcin level in Cushing's disease before and after treatment (1988) Horm Metab Res, 20, p. 70
• Chiodini, I., Carnevale, V., Torlontano, M., Fusilli, S., Guglielmi, Pileri, M., Modoni, S., Scillitani, A., Alteration of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: Study in eumenorrheic patients with Cushing's syndrome (1998) J Clin Endocrinol Metab, 83, pp. 1863-1867
• Osella, G., Terzolo, M., Reimondo, G., Piovesan, A., Pia, A., Termine, A., Paccotti, P., Angeli, A., Serum markers of bone and collagen turnover in patients with Cushing's syndrome and in subject with adrenal incidentalomas (1997) J Clin Endocrinol Metab, 82, pp. 3303-3307
• Guo, C.Y., Weetman, A.P., Eastell, R., Bone turnover and bone mineral density in patient with congenital adrenal hyperplasia (1996) Clin Endocrinol, 45, pp. 535-541
• Reid, I.R., Chapman, G.E., Fraser, T.R.C., Davies, A.D., Surus, A.S., Meyer, J., Huq, N.L., Ibbertson, H.K., Low serum osteocalcin levels in glucocorticoid-treated asthmatics (1986) J Clin Endocrinol Metab, 62, pp. 379-383
• Lukert, B.P., Higgins, J.C., Stoskopf, M.M., Serum osteocalcin is increased in patient with hyperthyroidism and decreased in patient receiving glucocorticoids (1986) J Clin Endocrinol Metab, 62, pp. 1056-1058
• Puolijoki, H., Risteli, J., Herrala, J., Risteli, L., Liippo, K., Effect of inhaled beclomethasone on serum markers of collagen metabolism in postmenopausal asthmatic women (1996) Respir Med, 90, pp. 339-342
• Struijs, A., Mulder, H., The effect of inhaled glucocorticoids on bone mass and biochemical markers of bone homeostasis: A 1-year study of beclomethasone versus budesonide (1997) Neth J Med, 50, pp. 233-237
• Abitbol, V., Roux, C., Chaussade, S., Guillemant, S., Kolta, S., Dougados, M., Couturier, D., Amor, B., Metabolic bone assessment in patients with inflammatory bowel disease (1995) Gastroenterology, 108, pp. 417-422
• Robinson, R.J., Iqbal, S.J., Wolfe, R., Patel, K., Abrams, K., Mayberry, J.F., The effect of rectally administered steroids on bone turnover: A comparative study (1998) Aliment Pharmacol Ther, 12, pp. 213-217
• Lems, W.F., Gerrits, M.I., Jacobs, J.W.G., Van Vugt, R.M., Van Rijn, H.J.M., Bijlsma, J.W.J., Change in (markers of) bone metabolism during high-dose corticosteroid pulse treatment in patient with rheumatoid arthritis (1996) Ann Rheum Dis, 55, pp. 288-293
• Sharif, M., Salisbury, C., Taylor, D.J., Kirwan, J.R., Changes in biochemical markers of joint tissue metabolism in a randomized controlled trial of glucocorticoid in early rheumatoid arthritis (1998) Arthritis Rheum, 41, pp. 1203-1209
• Wouters, M., Francois, A., Schoutens, A., Orloff, S., Reginster, J.Y., Does rheumatoid arthritis induce bone loss per se? (1988) Med Sci Res, 16, pp. 1215-1216
• Hall, G.M., Spector, T.D., Delmas, P.D., Markers of bone metabolism in postmenopausal women with rheumatoid arthritis: Effects of corticosteroids and hormone replacement therapy (1995) Arthritis Rheum, 38, pp. 902-906
• Valero, M.A., Leon, M., Ruiz Valdepenas, M.P., Larrodera, L., Lopez, M.B., Papapietro, K., Jara, A., Hawkins, F., Bone density and turnover in Addison's disease: Effect of glucocorticoid treatment (1994) Bone Miner, 26, pp. 9-17
• Conti, A., Sartorio, A., Ferrero, S., Feerario, S., Ambrosi, B., Modifications of biochemical markers of bone and collagen turnover during corticosteroid therapy (1996) J Endocrinol Invest, 19, pp. 127-130
• Pitt, P., Li, F., Todd, P., Webber, D., Pack, S., Moniz, C., A double-blind placebo-controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment (1998) Thorax, 53, pp. 351-356
• Adachi, J.D., Bensen, W.G., Brown, J., Hanley, D., Hodsman, A., Josse, R., Kendler, D.L., Chines, A.A., Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis (1997) N Engl J Med, 337, pp. 382-387
• Saag, K.G., Emkey, R., Schnitzer, T.J., Brown, J.P., Hawkins, F., Goemaere, S., Thamsborg, G., Daifotis, A.G., Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis (1998) N Engl J Med, 339, pp. 292-299
• Lems, W.F., Jacobs, W.G., Bijlsma, J.W.J., Croone, A., Haanen, H.C.M., Houben, H.H.M.L., Gerrits, M.I., Van Rijn, H.J.M., Effect of sodium fluoride on the prevention of corticosteroid-induced osteoporosis (1997) Osteoporos Int, 7, pp. 575-582
• Rizzoli, R., Chevalley, T., Slosman, D.O., Bonjour, J.P., Sodium monofluorophosphate increases vertebral bone mineral density in patients with corticosteroid-induced osteoporosis (1995) Osteoporos Int, 5, pp. 39-46